New Computational Model Predicts Gene Function
|
By LabMedica International staff writers Posted on 04 Mar 2010 |
Scientists have created a new computational model that can be utilized to predict gene function of uncharacterized plant genes with unprecedented speed and accuracy. The network, dubbed AraNet, has over 19,600 genes associated to each other by over one million links and can increase the discovery rate of new genes affiliated with a given trait tenfold. It is a huge advance to essential plant biology and agricultural research.
Of spite of the immense progress in functional characterization of plant genomes, over 30% of the 30,000 Arabidopsis genes have not yet been functionally characterized. Another third has little evidence regarding their role in the plant. "In essence, AraNet is based on the simple idea that genes that physically reside in the same neighborhood, or turn on in concert with one another are probably associated with similar traits,” explained corresponding author Dr. Sue Rhee at the Carnegie Institution for Science's (Washington, DC, USA) department of plant biology. "We call it guilt by association. Based on over 50 million scientific observations, AraNet contains over one million linkages of the 19,600 genes in the tiny, experimental mustard plant Arabidopsis thaliana. We made a map of the associations and demonstrated that we can use the network to propose that uncharacterized genes are linked to specific traits based on the strength of their associations with genes already known to be linked to those characteristics.”
The network allows for two main types of assessable theories. The first uses a set of genes known to be involved in a biologic process such as stress responses, as a "bait” to find new genes ("prey") involved in stress responses. The bait genes are linked to each other based on over 24 different types of experiments or computations. If they are linked to each other much more frequently or strongly than by chance, one can hypothesize that other genes that are as well linked to the bait genes have a high probability of being involved in the same process. The second testable hypothesis is to predict functions for uncharacterized genes. There are 4,479 uncharacterized genes in AraNet that have links to ones that have been characterized, so a significant portion of all the unknowns now gets a new hint as to their function.
The scientists tested the accuracy of AraNet with computational validation tests and laboratory experiments on genes that the network predicted as related. The researchers selected three uncharacterized genes. Two of them exhibited phenotypes that AraNet predicted. One is a gene that regulates drought sensitivity, now named Drought-sensitive 1 (Drs1). The other regulates lateral root development, called lateral root stimulator 1 (Lrs1). The researchers discovered that the network is much stronger forecasting correct associations than previous small-scale networks of Arabidopsis genes.
"Plants, animals, and other organisms share a surprising number of the same or similar genes--particularly those that arose early in evolution and were retained as organisms differentiated over time,” commented a lead and corresponding author Insuk Lee at Yonsei University of South Korea (Seoul). "AraNet not only contains information from plant genes, it also incorporates data from other organisms. We wanted to know how much of the system's accuracy was a result of plant data versus nonplant-derived data. We found that although the plant linkages provided most of the predictive power, the nonplant linkages were a significant contributor.”
"AraNet has the potential to help realize the promise of genomics in plant engineering and personalized medicine,” remarked Dr. Rhee. "A main bottleneck has been the huge portion of genes with unknown function, even in model organisms that have been studied intensively. We need innovative ways of discovering gene function and AraNet is a perfect example of such innovation. Food security is no longer taken for granted in the fast-paced milieu of the changing climate and globalized economy of the 21st century.”
The investigators published their findings January 31, 2010, in the advanced online issue of the journal Nature Biotechnology.
"Innovations in the basic understanding of plants and effective application of that knowledge in the field are essential to meet this challenge. Numerous genome-scale projects are underway for several plant species. However, new strategies to identify candidate genes for specific plant traits systematically by leveraging these high-throughput, genome-scale experimental data are lagging. AraNet integrates all such data and provides a rational, statistical assessment of the likelihood of genes functioning in particular traits, thereby assisting scientists to design experiments to discover gene function. AraNet will become an essential component of the next-generation plant research,” concluded Dr. Rhee.
Related Links:
Carnegie Institution for Science
Of spite of the immense progress in functional characterization of plant genomes, over 30% of the 30,000 Arabidopsis genes have not yet been functionally characterized. Another third has little evidence regarding their role in the plant. "In essence, AraNet is based on the simple idea that genes that physically reside in the same neighborhood, or turn on in concert with one another are probably associated with similar traits,” explained corresponding author Dr. Sue Rhee at the Carnegie Institution for Science's (Washington, DC, USA) department of plant biology. "We call it guilt by association. Based on over 50 million scientific observations, AraNet contains over one million linkages of the 19,600 genes in the tiny, experimental mustard plant Arabidopsis thaliana. We made a map of the associations and demonstrated that we can use the network to propose that uncharacterized genes are linked to specific traits based on the strength of their associations with genes already known to be linked to those characteristics.”
The network allows for two main types of assessable theories. The first uses a set of genes known to be involved in a biologic process such as stress responses, as a "bait” to find new genes ("prey") involved in stress responses. The bait genes are linked to each other based on over 24 different types of experiments or computations. If they are linked to each other much more frequently or strongly than by chance, one can hypothesize that other genes that are as well linked to the bait genes have a high probability of being involved in the same process. The second testable hypothesis is to predict functions for uncharacterized genes. There are 4,479 uncharacterized genes in AraNet that have links to ones that have been characterized, so a significant portion of all the unknowns now gets a new hint as to their function.
The scientists tested the accuracy of AraNet with computational validation tests and laboratory experiments on genes that the network predicted as related. The researchers selected three uncharacterized genes. Two of them exhibited phenotypes that AraNet predicted. One is a gene that regulates drought sensitivity, now named Drought-sensitive 1 (Drs1). The other regulates lateral root development, called lateral root stimulator 1 (Lrs1). The researchers discovered that the network is much stronger forecasting correct associations than previous small-scale networks of Arabidopsis genes.
"Plants, animals, and other organisms share a surprising number of the same or similar genes--particularly those that arose early in evolution and were retained as organisms differentiated over time,” commented a lead and corresponding author Insuk Lee at Yonsei University of South Korea (Seoul). "AraNet not only contains information from plant genes, it also incorporates data from other organisms. We wanted to know how much of the system's accuracy was a result of plant data versus nonplant-derived data. We found that although the plant linkages provided most of the predictive power, the nonplant linkages were a significant contributor.”
"AraNet has the potential to help realize the promise of genomics in plant engineering and personalized medicine,” remarked Dr. Rhee. "A main bottleneck has been the huge portion of genes with unknown function, even in model organisms that have been studied intensively. We need innovative ways of discovering gene function and AraNet is a perfect example of such innovation. Food security is no longer taken for granted in the fast-paced milieu of the changing climate and globalized economy of the 21st century.”
The investigators published their findings January 31, 2010, in the advanced online issue of the journal Nature Biotechnology.
"Innovations in the basic understanding of plants and effective application of that knowledge in the field are essential to meet this challenge. Numerous genome-scale projects are underway for several plant species. However, new strategies to identify candidate genes for specific plant traits systematically by leveraging these high-throughput, genome-scale experimental data are lagging. AraNet integrates all such data and provides a rational, statistical assessment of the likelihood of genes functioning in particular traits, thereby assisting scientists to design experiments to discover gene function. AraNet will become an essential component of the next-generation plant research,” concluded Dr. Rhee.
Related Links:
Carnegie Institution for Science
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







